Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081810 | SCV000113745 | benign | not specified | 2012-11-28 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000081810 | SCV000150431 | benign | not specified | 2015-09-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081810 | SCV000518983 | benign | not specified | 2015-12-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000472235 | SCV000563096 | benign | Oculofaciocardiodental syndrome | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316259 | SCV000851857 | likely benign | Inborn genetic diseases | 2016-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004703230 | SCV005209250 | likely benign | not provided | criteria provided, single submitter | not provided |